The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bahrt Kenneth since year 2005.
The trader's CIK number is 1527197.
At the time of this reporting, Bahrt Kenneth is the Chief Medical Officer of Oncobiologics, Inc. .
(stock ticker symbol ONS).
See this page for all insider trading activities at Oncobiologics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-10-15||SVNT||Savient Pharmaceuticals Inc||Sale||70,211||.08||5,757|
|2013-10-16||SVNT||Savient Pharmaceuticals Inc||Sale||8,000||.07||584|
|2013-04-30||SVNT||Savient Pharmaceuticals Inc||Sale||1,250||.74||925|
|2013-02-04||SVNT||Savient Pharmaceuticals Inc||Sale||29,000||1.02||29,724|
|2013-01-31||SVNT||Savient Pharmaceuticals Inc||Sale||1,300||1.03||1,339|
|2012-10-31||SVNT||Savient Pharmaceuticals Inc||Sale||1,000||1.45||1,450|
|2012-08-01||SVNT||Savient Pharmaceuticals Inc||Sale||4,950||.62||3,069|
|2011-11-16||SVNT||Savient Pharmaceuticals Inc||Buy||5,000||2.59||12,945|
|2011-09-14||SVNT||Savient Pharmaceuticals Inc||Buy||3,000||3.96||11,871|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bahrt Kenneth (Chief Medical Officer of Oncobiologics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.